Zytiga Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

ZYTIGA 500 mg tablets are purple, oval-shaped, film-coated tablets (20 mm long by 10 mm wide), debossed with "AA" on one side and "500" on the other side.
Each film-coated tablet contains 500 mg of abiraterone acetate equivalent to 446 mg of abiraterone.
Excipients with known effect: Each film-coated tablet contains 253.2 mg of lactose monohydrate and 13.5 mg of sodium.
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose (silicified), Croscarmellose sodium, Hypromellose 2910 (15 mPa.S), Lactose monohydrate, Magnesium stearate, Colloidal anhydrous silica, Sodium laurilsulfate.
Film-coat: Iron oxide black (E172), Iron oxide red (E172), Macrogol 3350, Polyvinyl alcohol, Talc, Titanium dioxide.

abiraterone

Manufacturer:

Johnson & Johnson

Distributor:

DCH Auriga - Healthcare

Four Star